ABCAM ORD 

$22.25
18
+$0.15+0.68% Wednesday 15:38

Statistics

Day High
22.25
Day Low
22.25
52W High
22.25
52W Low
22.25
Volume
4,002
Avg. Volume
0
Mkt Cap
0
P/E Ratio
2,225
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 20
$0.04
Nov 19
$0.11
Apr 19
$0.05
Nov 18
$0.11
Apr 18
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30JunExpected
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.04
0
0.04
0.08
Expected EPS
0
Actual EPS
0.0135

Financials

4.5%Profit Margin
Profitable
2016
2017
2018
2019
2020
2021
1.07BRevenue
47.98MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABCZF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap183.03B
Thermo Fisher Scientific offers a wide range of research and diagnostic solutions, directly competing with Abcam's product offerings in antibodies and reagents.
Danaher
DHR
Mkt Cap129.29B
Danaher, through its subsidiaries like Cytiva and Pall Corporation, provides similar life sciences tools and consumables, competing in the biotechnology and research sectors.
Illumina
ILMN
Mkt Cap24.66B
Illumina provides genomic sequencing solutions that are essential for research, competing with Abcam's offerings in the genomics and proteomics space.
Agilent Technologies
A
Mkt Cap38.25B
Agilent Technologies offers a broad range of analytical instruments and reagents, directly competing with Abcam in the life sciences and diagnostics markets.
Bio-Rad Laboratories
BIO
Mkt Cap8.36B
Bio-Rad Laboratories provides a variety of research and clinical diagnostic products that overlap with Abcam's portfolio, especially in antibody-based technologies.
Repligen
RGEN
Mkt Cap6.94B
Repligen offers bioprocessing technologies and products that support the development of biologic drugs, competing with Abcam's solutions for drug discovery and development.
Bio-Techne
TECH
Mkt Cap8.09B
Bio-Techne operates in similar markets as Abcam, offering reagents, instruments, and custom manufacturing services for research and diagnostic applications.
Qiagen NV
QGEN
Mkt Cap7.55B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in areas similar to Abcam's.
Mettler-Toledo International
MTD
Mkt Cap23.86B
Mettler-Toledo International offers precision instruments and services for research and development, competing with Abcam in the provision of lab equipment and supplies.
Waters
WAT
Mkt Cap37.66B
Waters Corporation specializes in analytical laboratory instrument and software, competing with Abcam in the life sciences sector, particularly in chromatography and mass spectrometry.

About

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Show more...
CEO
Mr. Markus Lusser
Employees
1760
Country
United Kingdom

Listings

0 Comments

Share your thoughts

FAQ

What is ABCAM ORD stock price today?
The current price of ABCZF is $22.25 USD — it has increased by +0.68% in the past 24 hours. Watch ABCAM ORD stock price performance more closely on the chart.
What is ABCAM ORD stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange ABCAM ORD stocks are traded under the ticker ABCZF.
What were ABCAM ORD earnings last quarter?
ABCZF earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ABCAM ORD revenue for the last year?
ABCAM ORD revenue for the last year amounts to 1.07B USD.
What is ABCAM ORD net income for the last year?
ABCZF net income for the last year is 47.98M USD.
Does ABCAM ORD pay dividends?
Yes, ABCZF dividends are paid semi-annual. The last dividend per share was 0.04 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does ABCAM ORD have?
As of June 03, 2026, the company has 1,760 employees.
In which sector is ABCAM ORD located?
ABCAM ORD operates in the Health & Wellness sector.
When did ABCAM ORD complete a stock split?
The last stock split for ABCAM ORD was on November 15, 2010 with a ratio of 5:1.
Where is ABCAM ORD headquartered?
ABCAM ORD is headquartered in Cambridge, United Kingdom.